Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Tokenizing Data to Improve Individual Health with Datavant

We have now entered a universe of “determinants of health” ranging from medical debt to housing to medication access to transportation…literally all things impact health that happen outside a doctor’s office. So is healthcare taking this into account? How are we helping those with substance abuse, rare cancers and unmanageable chronic conditions? On today’s episode…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Tokenizing Data to Improve Individual Health with Datavant

We have now entered a universe of “determinants of health” ranging from medical debt to housing to medication access to transportation…literally all things impact health that happen outside a doctor’s office.

So is healthcare taking this into account? How are we helping those with substance abuse, rare cancers and unmanageable chronic conditions?

On today’s episode of Healthcare Rethink, host Brian Urban, sits down with Claire Manneh, Head of Provider Research at Datavant, to talk about how the intuitive approach of tokenizing data is transforming how the healthcare ecosystem is reaching patients and improving lives!

Tune in to learn more about Claire’s public health background and her path to Datavant on this energizing episode!

The two discuss:

  1. What tokenization means and what it can do in healthcare and beyond
  2. How Claire’s work impacts health equity, health improvement
  3. Claire’s hopes for enabling lasting positive impact across the eco-system relative to data tokenization

Claire Manneh is the Head of Provider Research at Datavant. She graduated from the University of California, Berkeley and obtained a Bachelor’s Degree in Political Science and Government; Public Health Degree, Political Science, and Government.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Leading with Purpose: Dr. David Foster on Faith, Healthcare Leadership, and Physician Collaboration

Dr. David Foster discusses the importance of faith in healthcare leadership and the role of physician collaboration. The conversation emphasizes how values-driven leadership can positively impact patient care. The dialogue also explores the significance of integrating personal beliefs in professional settings.

  • 01Values-driven leadership can significantly enhance patient care.
  • 02Integrating personal beliefs in professional settings can benefit healthcare leadership.
  • 03Collaboration among physicians is crucial for effective healthcare leadership.

Aug 4, 2026

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health venture funding reached $7.4B in the first half of 2026, with significant investments in AI agent platforms and chronic care tools. Mega-deals of over $100 million were a key driver of the funding surge.

  • 01Digital health VC funding hit $7.4 billion in the first half of 2026.
  • 02Mega-deals in AI agent platforms and chronic care tools exceeded $100 million.
  • 03AI, chronic care, and workforce tools dominate digital health investments.

Aug 4, 2026

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Three significant transactions occurred in the pharmaceutical and medtech sectors on August 3, highlighting a split M&A market. While mid-market buyouts such as KKR's acquisition of Integer Holdings and Curium's purchase of Lantheus proceeded, larger megamergers like AstraZeneca's faced obstacles. This suggests a trend towards restructuring within the industry.

  • 01KKR acquired Integer Holdings for $5.7 billion.
  • 02Curium purchased Lantheus in an $8 billion deal.
  • 03AstraZeneca's megamerger attempt was blocked.

Aug 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512